Attempts to eradicate or at least reduce disease burdens in less-developed countries have faced another blow to their credibility, with the appearance of a report by William Easterly, co-director of the US New York University's Development Research Institute, into claims of success in countering malaria. The Bill & Melinda Gates Foundation, which already attracts criticism over fears that its sheer size can create distortions to the local economies where it operates, issued data claiming that Zambia had experienced a 50% drop in child malaria rates. Similar improvements were alleged to have been made in Ethiopia.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
| Headless Content Management with Blaze